{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:37:40Z","timestamp":1782934660679,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>There is a lack of data on post-HSCT non-osteopenic bone pathology specifically for children with inborn errors of immunity (IEI). We collected data on non-osteopenic bone pathology in children with IEI post-HSCT over two decades in a large tertiary pediatric immunology center.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Descriptive study with data analysis of bone pathology in\u00a0allo-HSCT  for IEI was performed between 1\/1\/2000 to 31\/12\/2018 including patients alive at follow-up to July 2022. Records were analyzed for bone pathology and risk factors. Exclusion criteria included isolated reduced bone density, fractures, and skeletal anomalies due to underlying IEI and short stature without other bone pathology. Bone pathologies were divided into 5 categories: bone tumors; skeletal dysplasia; avascular necrosis; evolving bone deformities; slipped upper femoral epiphysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 429 children received HSCT between 2000 and 2018; 340 are alive at last assessment. Non-osteopenic bone pathology was observed post-HSCT in 9.4% of patients (32\/340, mean 7.8\u00a0years post-HSCT). Eleven patients (34%) had\u2009&gt;\u20091 category of bone pathology. Seventeen patients (17\/32; 53%) presented with bilateral bone pathology. The majority of patients received treosulfan-based conditioning (26\/32; 81.2%). Totally, 65.6% (21\/32) of patients had a history of prolonged steroid use (&gt;\u20096\u00a0months). Pain was the presenting symptom in 66% of patients, and surgical intervention was required in 43.7%. The highest incidence of bone pathologies was seen in Wiskott-Aldrich syndrome (WAS) (<jats:italic>n<\/jats:italic>\u2009=\u20098\/34; 23.5%) followed by hemophagocytic lymphohistiocytosis patients (<jats:italic>n<\/jats:italic>\u2009=\u20093\/16; 18.8%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Non-osteopenic bone pathology in long-term survivors of allo-HSCT for IEI is not rare. Most patients did not present with complaints until at least 5\u00a0years post-HSCT highlighting the need for ongoing bone health assessment for patients with IEI. Children presenting with stunted growth and bone pathology post-HSCT should undergo skeletal survey to rule out development of post-HSCT skeletal dysplasia. Increased rates and complexity of bone pathology were seen amongst patients with Wiskott-Aldrich syndrome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10875-023-01465-z","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:50:23Z","timestamp":1679878223000},"page":"1019-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity"],"prefix":"10.1007","volume":"43","author":[{"given":"Zainab M.","family":"Golwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita Gireesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Xu-Bayford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Stankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike A.","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-4251","authenticated-orcid":false,"given":"Reem","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1465_CR1","doi-asserted-by":"publisher","unstructured":"Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol. 2013.\u00a0https:\/\/doi.org\/10.1200\/JCO.2012.46.6193. Erratum in: J Clin Oncol. 2013;31(23):2977.","DOI":"10.1200\/JCO.2012.46.6193"},{"issue":"5","key":"1465_CR2","first-page":"503","volume":"63","author":"CJ McGarigle","year":"1990","unstructured":"McGarigle CJ. Long-term follow-up of bone marrow transplant patients. Yale J Biol Med. 1990;63(5):503\u20138.","journal-title":"Yale J Biol Med"},{"key":"1465_CR3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12949","author":"A Tichelli","year":"2008","unstructured":"Tichelli A, Passweg J, W\u00f3jcik D, Rov\u00f3 A, Harousseau JL, Masszi T, et al. EBMT. Late Effects Working Party Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008. https:\/\/doi.org\/10.3324\/haematol.12949.","journal-title":"Haematologica"},{"key":"1465_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/s1658-3876(10)50025-6","author":"AO Soubani","year":"2010","unstructured":"Soubani AO, Pandya CM. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2010. https:\/\/doi.org\/10.1016\/s1658-3876(10)50025-6.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"1465_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4669-4","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, et al. Bone management in hematologic stem cell transplant recipients. Osteoporos Int. 2018. https:\/\/doi.org\/10.1007\/s00198-018-4669-4.","journal-title":"Osteoporos Int"},{"key":"1465_CR6","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.39","author":"S Bhatia","year":"2011","unstructured":"Bhatia S. Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev Hematol. 2011. https:\/\/doi.org\/10.1586\/ehm.11.39.","journal-title":"Expert Rev Hematol"},{"key":"1465_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704360","author":"SC Kaste","year":"2004","unstructured":"Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004. https:\/\/doi.org\/10.1038\/sj.bmt.1704360.","journal-title":"Bone Marrow Transplant"},{"key":"1465_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","author":"R Castagnoli","year":"2019","unstructured":"Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front Pediatr. 2019. https:\/\/doi.org\/10.3389\/fped.2019.00295.","journal-title":"Front Pediatr"},{"key":"1465_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.012","author":"F Pirsl","year":"2016","unstructured":"Pirsl F, Curtis LM, Steinberg SM, Tella SH, Kati\u0107 M, Dobbin M, et al. Characterization and risk factor analysis of osteoporosis in a large cohort of patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2016. https:\/\/doi.org\/10.1016\/j.bbmt.2016.04.012.","journal-title":"Biol Blood Marrow Transplant."},{"key":"1465_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29316","author":"BH Kushner","year":"2015","unstructured":"Kushner BH, Roberts SS, Friedman DN, Kuk D, Ostrovnaya I, Modak S, et al. Osteochondroma in long-term survivors of high-risk neuroblastoma. Cancer. 2015. https:\/\/doi.org\/10.1002\/cncr.29316.","journal-title":"Cancer"},{"key":"1465_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/2FBPO.0000000000000081","author":"EA King","year":"2014","unstructured":"King EA, Hanauer DA, Choi SW, Jong N, Hamstra DA, Li Y, et al. Osteochondromas after radiation for pediatric malignancies: a role for expanded counseling for skeletal side effects. J PediatrOrthop. 2014. https:\/\/doi.org\/10.1097\/2FBPO.0000000000000081.","journal-title":"J PediatrOrthop"},{"key":"1465_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703424","author":"P Bordigoni","year":"2002","unstructured":"Bordigoni P, Turello R, Clement L, Lascombes P, Leheup B, Galloy MA, et al. Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases. Bone Marrow Transplant. 2002. https:\/\/doi.org\/10.1038\/sj.bmt.1703424.","journal-title":"Bone Marrow Transplant"},{"key":"1465_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/1043454207313322","author":"K Ruble","year":"2008","unstructured":"Ruble K. Skeletal complications after bone marrow transplant in childhood. J Pediatr Oncol Nurs. 2008. https:\/\/doi.org\/10.1177\/1043454207313322.","journal-title":"J Pediatr Oncol Nurs"},{"key":"1465_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.003","author":"M Faraci","year":"2009","unstructured":"Faraci M, Bagnasco F, Corti P, Messina C, Fagioli F, Podda M, et al. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group. Biol Blood Marrow Transplant. 2009. https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.003.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1465_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62021","author":"LD Botto","year":"2021","unstructured":"Botto LD, Meeths M, Campos-Xavier B, Bergamaschi R, Mazzanti L, Scarano E, et al. Chondrodysplasia and growth failure in children after early hematopoietic stem cell transplantation for non-oncologic disorders. Am J Med Genet A. 2021. https:\/\/doi.org\/10.1002\/ajmg.a.62021.","journal-title":"Am J Med Genet A"},{"key":"1465_CR16","doi-asserted-by":"publisher","unstructured":"Connelly M, Weiss JE; for the CARRA Registry Investigators. Pain, functional disability, and their association in juvenile fibromyalgia compared to other pediatric rheumatic diseases. PediatrRheumatol Online J. 2019;17(1):72. Erratum in: PediatrRheumatol Online J. 2020. https:\/\/doi.org\/10.1186\/s12969-019-0375-9.","DOI":"10.1186\/s12969-019-0375-9"},{"key":"1465_CR17","first-page":"7","volume":"5","author":"B Serio","year":"2013","unstructured":"Serio B, Pezzullo L, Fontana R, Annunziata S, Rosamilio R, Sessa M, et al. Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa. 2013;5:7\u201313.","journal-title":"Transl Med UniSa"},{"key":"1465_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.12.567","author":"X Li","year":"2014","unstructured":"Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, et al. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Biol Blood Marrow Transplant. 2014. https:\/\/doi.org\/10.1016\/j.bbmt.2013.12.567.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1465_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24474","author":"S Campbell","year":"2009","unstructured":"Campbell S, Sun CL, Kurian S, Francisco L, Carter A, Kulkarni S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer. 2009. https:\/\/doi.org\/10.1002\/cncr.24474.","journal-title":"Cancer"},{"key":"1465_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.12.009","author":"MB Heneghan","year":"2016","unstructured":"Heneghan MB, Rheingold SR, Li Y, Seif AE, Huang YS, McLeod L, et al. Treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2016. https:\/\/doi.org\/10.1016\/j.clml.2015.12.009.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1465_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/bpb.0000000000000718","author":"S Baghdadi","year":"2021","unstructured":"Baghdadi S, Mortazavi SMJ, Dastoureh K, Moharrami A, Baghdadi T. Middle to long-term results of distal femoral tension band hemiepiphysiodesis in the treatment of idiopathic genu valgum. J PediatrOrthop B. 2021. https:\/\/doi.org\/10.1097\/bpb.0000000000000718.","journal-title":"J PediatrOrthop B"},{"key":"1465_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/2Fs11892-014-0508-y","author":"MI Goran","year":"2003","unstructured":"Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003. https:\/\/doi.org\/10.1007\/2Fs11892-014-0508-y.","journal-title":"J Clin Endocrinol Metab"},{"key":"1465_CR23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-1067","author":"DC Perry","year":"2018","unstructured":"Perry DC, Metcalfe D, Lane S, Turner S. Childhood obesity and slipped capital femoral epiphysis. Pediatrics. 2018. https:\/\/doi.org\/10.1542\/peds.2018-1067.","journal-title":"Pediatrics"},{"key":"1465_CR24","doi-asserted-by":"publisher","unstructured":"Wirth T. Epiphyseolysis capitis femoris [Slipped upper femoral epiphysis (SUFE)]. Z OrthopUnfall. 2011. German. https:\/\/doi.org\/10.1055\/s-0031-1280167.","DOI":"10.1055\/s-0031-1280167"},{"key":"1465_CR25","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47250-0","author":"J Roesler","year":"2007","unstructured":"Roesler J. Important role of corticosteroids in chronic granulomatous disease. J Med Microbiol. 2007. https:\/\/doi.org\/10.1099\/jmm.0.47250-0.","journal-title":"J Med Microbiol"},{"key":"1465_CR26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-115253","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia RM. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009. https:\/\/doi.org\/10.1182\/blood-2008-12-115253.","journal-title":"Blood"},{"key":"1465_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.05.019","author":"NS Soysa","year":"2016","unstructured":"Soysa NS, Alles N. Osteoclast function and bone-resorbing activity: an overview. BiochemBiophys Res Commun. 2016. https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.019.","journal-title":"BiochemBiophys Res Commun"},{"key":"1465_CR28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m608957200","author":"MA Chellaiah","year":"2007","unstructured":"Chellaiah MA, Kuppuswamy D, Lasky L, Linder S. Phosphorylation of a Wiskott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption. J Biol Chem. 2007. https:\/\/doi.org\/10.1074\/jbc.m608957200.","journal-title":"J Biol Chem"},{"key":"1465_CR29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1259","author":"Y Calle","year":"2004","unstructured":"Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow J, et al. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood. 2004. https:\/\/doi.org\/10.1182\/blood-2003-04-1259.","journal-title":"Blood"},{"key":"1465_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/adc.48.10.818","author":"G McEnery","year":"1973","unstructured":"McEnery G, Nash FW. Wiskott-Aldrich syndrome associated with idiopathic infantile cortical hyperostosis (Caffey\u2019s disease). Arch Dis Child. 1973. https:\/\/doi.org\/10.1136\/adc.48.10.818.","journal-title":"Arch Dis Child"},{"key":"1465_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/bf00441979","author":"M Abinun","year":"1988","unstructured":"Abinun M, Mikuska M, Filipovi\u0107 B. Infantile cortical hyperostosis associated with the Wiskott-Aldrich syndrome. Eur J Pediatr. 1988. https:\/\/doi.org\/10.1007\/bf00441979.","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01465-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01465-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01465-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T07:15:54Z","timestamp":1686899754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01465-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01465-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research was ethically approved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was taken from parents\/legal guardians together from patients as appropriate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participation"}},{"value":"Informed consent was taken from parents\/legal guardians together from patients as appropriate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}